Alembic Pharmaceuticals Ltd has posted a 14% increase in its net profit for the fourth quarter of FY2025, reaching Rs. 24 crore, compared to Rs. 21 crore in the same period last year. The company also reported a growth in revenue, which climbed to Rs. 60 crore in Q4, up from Rs. 49 crore during the previous fiscal. For the entire year, Alembic’s net profit surged to Rs. 145 crore, marking a significant increase from Rs. 93 crore in FY2024. The company's shares saw a modest gain of 0.27% on the BSE.